BioCurex, Inc.(fka BOCX)

[Kag]

Bocxman,
The SEC temporary trading suspension in April 2004 was likely the intended extent of SEC’s action against BioCurex. Investigations take time and cost money. In this case, the SEC was both the judge and jury. The trading suspension was nothing short of a SEC enforcement action to motivate BioCurex management to basically shape up. Companies slapped with a SEC trading suspension are not allowed a Wells process. It was a quick, inexpensive, effective enforcement action that is available for use by the SEC. Read the paragraph below which was written by an attorney who spent more than 12 years in the enforcement division of the SEC. kag

"Trading suspensions are one of the most aggressive enforcement tools in the SEC’s enforcement arsenal because they can be crippling to a public company of any size. While trading suspensions shut down the market for a stock, the SEC is not required to inform a company of its intended proceedings. Indeed, companies subject to trading suspensions are not given the opportunity to convince the SEC commissioners that such proceedings is unwarranted, an opportunity called the “Wells process.”